Can B-Cell Depletion With Rituximab Trigger Psoriasis?
Monday, August 13, 2007
Three patients who developed new-onset psoriasis after rituximab (Rituxan®) treatment have raised a troubling new concern about the growing use of this B-cell depleting therapy in a widening group of rheumatic diseases. The cases are reported in the August issue of Arthritis & Rheumatism.
On the go?
Text INFO to 50555 and opt-in to receive breaking news about lupus on your mobile phone.
Message and Data Rates May Apply. Text STOP to 50555 to STOP. Text HELP to 50555 for HELP. Full Terms